December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]
340B Health Urges HHS to Start Enforcing Regulation to Police Drug Industry Overcharging
September 20, 2017— The U.S. Department of Health and Human Services should not delay a long-overdue federal regulation to punish drug manufacturers that illegally overcharge safety-net hospitals and other healthcare providers for lifesaving medicines, thousands of safety-net providers enrolled in the federal 340B drug discount program said in written comments to HHS … [Read more...]